In the pathogenesis of MM, upregulation of inflammatory pathways that mediate nuclear factor-kB and interleukin-6, as well as dysregulation of endogenous growth factors including insulin-like growth factor-1 and insulin, have well-documented roles (11–17). Here, IGF1 is linked to Miyoshi myopathy.